Episode 143 | James Hamet, CEO at Vistim Labs | Building a Go-To-Market Strategy for an AI Diagnostic

from Project Medtech · host Project Medtech

In this episode, James Hamet at Vistim Labs and Duane Mancini discuss licensing technology from a university, voice of customer, neurodegenerative diseases, the importance of your economic story, why they are focusing on clinical data, and so much more. James Hamet LinkedIn Vistim Labs Website Project Medtech Website Project Medtech LinkedIn Duane Mancini LinkedIn

Episode metadata supplied by the publisher feed · Published Jun 12, 2023

Embed this episode

Attribution link and audio player

Ready to play

Episode 143 | James Hamet, CEO at Vistim Labs | Building a Go-To-Market Strategy for an AI Diagnostic

0:00 54:36

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Project Medtech?

This episode is 54 minutes long.

When was this Project Medtech episode published?

This episode was published on June 12, 2023.

Can I download this Project Medtech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!